Skip to main content

Coronavirus Vaccine: 7 Participants Disqualified From Oxford Phase III Trials, Factors That Are Considered

By Unknown

01/8 COVID-19 vaccine trials are happening in an advanced manner

Vaccine trials are going on in an unprecedented manner across India and the globe, considering the urgency of the COVID-19 pandemic. Most of the vaccines under contention right now are way into phase II and III of trials, with high hopes that we'll see a vaccine ready by early months of 2021.

While most vaccine trials are split according to the objectives and safety studies, an inclusive vaccine trial makes sure that all aspects are considered before a vaccine is approved for use. Hence, phase III, considered to be the most crucial leg of trials involves a large group of volunteers, from varied categories and age groups.

02/8 Can someone be disqualified from a vaccine trial?

However, even though some groups are running 'short' of volunteers, there are others who are not accepted into phase III trials. Oxford-AstraZeneca, which is one of the most promising vaccine candidates is running phase III trials in India as 'Covishield'. While the testing is seeing an active response from the public, recent reports have suggested that at least seven participants have been found ineligible for vaccine testing, as the Serum Institute of India began phase III testing at a government facility in Pune.

According to an agency report, the volunteers in question were disqualified because of medical reasons and would be screened again this week.

"All seven candidates who were selected on Monday have become ineligible due to various medical reasons, including antibody test coming positive for some...Some more candidates have been screened today (Tuesday) and if their results in the antibody and COVID-19 tests are negative and if they are eligible on other medical grounds, they will be administered vaccine candidate.."

It should be noted that while volunteers, in any trial have the option to opt-out or leave the trial at any time, there are specific guidelines as to who can enrol for the trial, be tested on, followed globally.


03/8 What is the enrolment strategy for vaccine trials right now?


Not just for novel coronavirus, but selecting participants for any vaccine trial is a tedious process. That being said, there are some cannot participate:

04/8 Pregnant women

Not only are pregnant women immuno-compromised (since the body is providing nourishment for two), vaccine trials could expose them to certain side-effects which could be harmful to the unborn baby and their reactions may be slightly different to that of non-pregnant women. The doses experimented with could also be high for use during pregnancy, which again could lead to unwelcome complications. It is usually required that only women who are not planning for a baby, or have had a child in the past year or so participate.


While this is a standard practice being followed since years, some small studies have made exceptions for the category. However, pregnant women are largely kept away from coronavirus vaccine trials.

05/8 Those who have already been infected or have antibodies


A vaccine trial works to test whether or not a vaccine delivers immunogenicity response and spikes antibodies in the test body. Now, for someone who has already had the infection, there will be enough antibodies present (even if temporary) which can make it difficult to ascertain results of the vaccine's workability. Hence, one of the criteria for vaccine trial eligibility is for a volunteer to be healthy, and have not had coronavirus infection recently.

06/8 Those who are on any kind of medication or steroids


People who are put on any kind of medication or steroid supplements can showcase an altered response to the vaccine. Hence, it's preferred that volunteers who register for the trial have not have undergone recent surgery or any operation, for which they might have been advised medications.

07/8 People with underlying medical conditions


Underlying medical conditions come under the high-risk category, considering they impact your immunity. The vaccine may not deliver the best results, or may expose them to certain side-effects, which may not be the most favourable in trials. Even if high-risk volunteers are included, they are subject to a lot of regulation and monitoring, in mid-stage level.

08/8 Those who might be living far-off


While distance isn't the most crucial criteria, trial investigators prefer enrolling people who live nearby. This is primarily because vaccine trials involve regular monitoring and observing patients for any side-effects, or symptoms. Living far off may find it difficult to follow up for regular consultations and checks. This, experts feel is also a reason why women, of childrearing age, are not preferred for the trial, since they may find it difficult to follow up.

Comments

Post a Comment

Popular posts from this blog

Increased risks of drop out for women and girls : CoronaVirus Updates

By Unknown
The total number of children not returning to their education after the school closures is likely to be significant. The pandemic also risks jeopardizing some of the gains made since 2001 in re-building women and girls’ education following the Taliban regime.  The COVID-19 pandemic is creating additional barriers due to risks—and students’ and parents’ anxiety about risks—associated with children returning to classrooms that are cramped, with no capacity for distancing, often cold, damp and poorly ventilated during the country’s severe winters, and have no or poor hygiene and clean water facilities. The COVID-19 pandemic is likely to drive many women and girls out of education permanently. School closures due to COVID-19, resulting increases in caregiving responsibilities for women and girls, and increases in poverty and unemployment will all make it harder for women and girls to study.  These factors combine in harmful ways with pre-existing discriminatory gender norms, o...
Post a Comment
Read more

Iran, Russia Discussing Joint Production Of COVID-19 Vaccine

By Unknown
Iran and Russia's sovereign wealth fund RDIF are discussing the joint production of a vaccine against COVID-19, Russian news agencies cited the Iranian ambassador to Moscow as saying on Friday. "We are holding talks, I spoke with the head of RDIF Kirill Dmitriev, our officials have held several rounds of consultations and we announced that we will co-operate," Ambassador to Moscow Kazem Jalali was cited as saying. Thus far, Russia has struck a manufacturing partnership deal with India, which is due to produce 300 million doses of the 'Sputnik-V' vaccine domestically. It is also discussing such partnerships with several other countries, including Brazil.
Post a Comment
Read more

Covid - 19 Effect : Increased risks of violence against women and girls, exploitation and child marriage

By Unknown
In addition to dropping out of school, education disruption puts girls and young women at increased risk of numerous abuses: child marriage, exploitation, child labor, early pregnancy, and gender-based violence.  School closures, the loss of protective spaces provided by school, lockdowns spent at home and COVID-19 mitigation measures disrupt children›s routine, and place new stressors on parents and caregivers, contributing to an increase in the severity and frequency of domestic violence across the country. School closures represent the loss of a safe space, where girls who are experiencing violence and abuse can find respite, and where there is an opportunity for adults to identify signs of abuse and intervene in their lives. School closures and the socio-economic impact of COVID-19 have increased the risk of reliance on negative coping mechanisms, such as child marriage. With many families losing their means of livelihood, girls are at increased risk of being forced to drop...
Post a Comment
Read more